Lupin receives tentative U.S. FDA approval for Siponimod Tablets EP News Bureau Dec 5, 2025 Approval covers 0.25 mg, 1 mg and 2 mg strengths for multiple sclerosis treatment
Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules EP News Bureau Nov 13, 2025 The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…
